Table 1.
Antibody Type |
Age at Entry, y |
Overall | |||
---|---|---|---|---|---|
<8 | 8–11 | 12–17 | >18 | ||
GADA, n | 107 | 113 | 117 | 372 | 709 |
Risk, % | 35 (24–46) | 38 (24–51) | 28 (14–41) | 16 (10–22) | 25 (20–30) |
IAA, n | 69 | 33 | 43 | 91 | 236 |
Risk, % | 37 (22–52) | 4 (0–11) | 13 (0–34) | 13 (0–25) | 19 (11–27) |
IA-2A, n | 7 | 11 | 9 | 22 | 49 |
Risk, % | Insufficient number of participants to assess | 23 (7–38) |
Values in parentheses are 95% CIs.